Rapid Access to Intervention Development (RAID)

Description:
The National Cancer Institute (NCI) is requesting project proposals in response to the on-going Rapid Access to Intervention Development (RAID) Program. The RAID Program will make available to academic investigators, on a competitive basis, the preclinical development contract resources of NCI's Developmental Therapeutics Program (DTP). The goal of the RAID Program is the rapid movement of novel molecules and concepts from the laboratory to the clinic for proof-of-principle clinical trials. The RAID Program will assist investigators who submit successful project proposals by providing any (or all) of the preclinical development steps that may be obstacles to clinical translation. Possible tasks may include production, bulk supply, good manufacturing process (GMP) manufacturing, formulation, and toxicology. Suitable agents for RAID will include small molecules, biologics, or vaccines.

Web Site:
Developmental Therapeutics Program http://dtp.nci.nih.gov/

Contact:
Raid,Office Of Associate Director Raid, 301-496-8720; raid@dtpax2.ncifcrf.gov

This page last updated 2008-04-07 13:09:34